These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 10352189

  • 1. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
    Laluck BJ, Cattran DC.
    Am J Kidney Dis; 1999 Jun; 33(6):1026-32. PubMed ID: 10352189
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
    Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C.
    Nephrol Dial Transplant; 1989 Jun; 4(6):525-9. PubMed ID: 2507973
    [Abstract] [Full Text] [Related]

  • 3. Prognosis of untreated patients with idiopathic membranous nephropathy.
    Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G.
    N Engl J Med; 1993 Jul 08; 329(2):85-9. PubMed ID: 8510707
    [Abstract] [Full Text] [Related]

  • 4. Remissions and relapses in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M.
    Nephrol Dial Transplant; 1992 Jul 08; 7 Suppl 1():85-90. PubMed ID: 1337188
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
    Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D, Praga M, Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).
    Nephrol Dial Transplant; 2012 Jan 08; 27(1):231-4. PubMed ID: 21624942
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 08; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 7. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 08; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of steroid therapy in different stages of membranous nephropathy.
    Fuiano G, Stanziale P, Balletta M, Sepe V, Marinelli G, Comi N, Esposito A, Andreucci VE.
    Nephrol Dial Transplant; 1989 Jan 08; 4(12):1022-9. PubMed ID: 2517322
    [Abstract] [Full Text] [Related]

  • 9. [Membranous glomerulonephritis].
    Polenaković M.
    Srp Arh Celok Lek; 1996 Jan 08; 124 Suppl 1():18-25. PubMed ID: 9102898
    [Abstract] [Full Text] [Related]

  • 10. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2006 Feb 08; 21(2):389-96. PubMed ID: 16234291
    [Abstract] [Full Text] [Related]

  • 11. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul 08; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug 08; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 13. Treatment of membranous lupus nephritis.
    Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C.
    Am J Kidney Dis; 1998 Apr 08; 31(4):681-6. PubMed ID: 9531186
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 15. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug 05; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 16. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 05; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
    Chin Med J (Engl); 2001 Dec 15; 114(12):1305-8. PubMed ID: 11793859
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S.
    N Engl J Med; 1989 Jan 26; 320(4):210-5. PubMed ID: 2643046
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
    Nephrol Dial Transplant; 2009 Oct 26; 24(10):3082-8. PubMed ID: 19465558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.